Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlerHuEpo TREATMENT IN LOW-RISK MYELODYSPLASTIC SYNDROMES: A REPLY.AuthorsGrossi, AlbertoAbstractResponds to a commentary about the use of recombinant human erythropoietin in the treatment of low-risk myelodysplastic syndromes. Effectiveness of MDS to rHuEpo treatment; Factors associated with reduced response to rHuEpo treatment.SubjectsMYELODYSPLASTIC syndromes treatment; RECOMBINANT erythropoietin; THERAPEUTICSPublicationBritish Journal of Haematology, 1999, Vol 106, Issue 2, p574ISSN0007-1048Publication typeArticleDOI10.1046/j.1365-2141.1999.1622a.x